Fig. 2From: Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapyPercentage of cell surface NCL expression in NB tumors and in BM-infiltrating NB cells. Single cell suspension from patient-derived tumors (A) and BM-infiltrating NB cells (B) were incubated for 25 mi at 4 °C with anti-CD45, anti-CD56, anti-GD2, anti-B7-H3 and anti-NCL moAbs, and analyzed by FC. Bars in scatter plots represent mean percentage (%) of positivityBack to article page